STUDY,PART,SUBJECT,THERAPY,START,END,BEST_RESPONSE
,,E23456,Regorafenib,05/01/2017,10/06/2017,Active disease
,,E23456,Sunitinib,05/01/2014,05/31/2017,Active disease
,,E23456,Imatinib,01/01/2012,12/31/2014,Active disease
,,E23456,PAKT Study(weekly taxol) + STDY5 363/ PLACEBO,06/29/2016,02/15/2017,Active disease
,,E23456,CAPECITABINE  28/02/17 - 13/07/17 ERIBULIN 25/07/17- 13/11/2017,02/28/2017,07/13/2017,Active disease
,,E34567,IrMdG chemotherapy,02/01/2016,06/30/2017,Stable disease
,,E34567,Adjuvant Oxaliplatin / Capecitabine,07/01/2014,01/31/2015,Stable disease
,,E34567,gemcitabine and carboplatin,08/17/2017,11/15/2017,Stable disease
,,E34567,fulvestrant and zometa,04/27/2017,07/28/2017,Stable disease
,,E34567,17/10/2016-  10/04/2017 𐤥Eribulin and zometa 26/10/15-3/10/16 �Taxol and zometa Jul/14 - Oct 2015 - 𐀶Capecitabine       26/10/15-3/10/16  Taxol + zometa July 2014-Oct 2015   capecitabine1234567890123456789012345678901234567890123456...,10/17/2016,04/10/2017,Stable disease